GFALMB2019
Recruiting
1,000 enrolled
BOOSTER
Recruiting
300 enrolled
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Recruiting
30 enrolled
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
Active not recruiting
153 enrolled
CAR T-cell Long-Term Follow-Up, Quality of Life and Adverse Reactions
Recruiting
80 enrolled
Blinatumomab Consolidation in Real World
Recruiting
200 enrolled
Long-term Follow-up Study of Patients Receiving CAR-T Cells
Recruiting
500 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
Completed
406 enrolled
Registry of Older Patients With Cancer
Recruiting
3,000 enrolled
Gut Health in Children With Cancer
Recruiting
40 enrolled
Immunotherapy in Lymphoma
Recruiting
72 enrolled
PROSECO
Completed
592 enrolled
Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin
Completed
10 enrolled 3 charts
CARTCO
Completed
150 enrolled
GICCA
Unknown
2,500 enrolled
Collecting and Storing Blood Samples From Patients With Cancer
Withdrawn
Monitoring Minimal Residual Disease(MRD)in Pediatric B-acute Lymphoblastic Leukemia
Unknown
255 enrolled
REALYSA
Recruiting
6,000 enrolled
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Terminated
150 enrolled
Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
Completed
9 enrolled 4 charts
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Terminated
1,000 enrolled
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
Completed
36 enrolled
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant
Completed
459 enrolled
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Completed
54 enrolled
Blood Samples From Patients on a Clinical Trial to CINV During HSCT
Terminated
9 enrolled
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Completed
41 enrolled
Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma
Completed
17 enrolled
RBL
Completed
43 enrolled
Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
Completed
391 enrolled
Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202
Completed
9 enrolled
Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Completed
36 enrolled
Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers
Withdrawn
Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant
Terminated
24 enrolled
Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer
Terminated
48 enrolled
Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant
Withdrawn
CFM
Completed
175 enrolled
Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
Terminated
252 enrolled
Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer
Completed
750 enrolled
Studying Fentanyl in Patients With Cancer
Terminated
2 enrolled
PET Study in Patients With Non-Hodgkin Lymphoma
Completed
55 enrolled
COMETH
Completed
85 enrolled
Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation
Completed
168 enrolled
Quality of Life in Younger Leukemia and Lymphoma Survivors
Completed
48 enrolled
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases
Terminated
60 enrolled
Heparin or Enoxaparin in Patients With Cancer
Completed
6 enrolled